Leonard Braden Michael's Form 4 filing
Aclaris Therapeutics, Inc. (ACRS) · filed Jul 5, 2024
- Accession no.
- 0001373604-24-000045
- Filed
- Jul 5, 2024
- Trade date
- Jul 2-5, 2024
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $405.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Leonard Braden MichaelCIK 0001373603 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 2, 2024 | Common Stock | PPurchaseAcquired | +86,092 | $1.14 | +$98,144.88 | 13,181,664 | Indirect | |
| Jul 3, 2024 | Common Stock | PPurchaseAcquired | +143,288 | $1.16 | +$166,214.08 | 13,324,952 | Indirect | |
| Jul 5, 2024 | Common Stock | PPurchaseAcquired | +123,017 | $1.15 | +$141,469.55 | 13,447,969 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.